New directions in diagnostic evaluation of insect allergy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Golden, 2011, AAAAIStinging insect hypersensitivity: a practice parameter update 2011., J Allergy Clin Immunol, 127, 852, 10.1016/j.jaci.2011.01.025
Bernstein, 2008, Allergy diagnostic testing: an updated practice parameter., Ann Allergy Asthma Immunol, 100, S1
Hamilton, 2010, Clinical laboratory assessment of immediate-type hypersensitivity., J Allergy Clin Immunol, 125, S284, 10.1016/j.jaci.2009.09.055
Golden, 1989, Epidemiology of insect venom sensitivity., JAMA, 262, 240, 10.1001/jama.1989.03430020082033
Golden, 2006, Clinical and entomological factors influence the outcome of sting challenge studies., J Allergy Clin Immunol, 117, 670, 10.1016/j.jaci.2005.12.1313
Rueff, 2009, Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase - a study of the EAACI Interest Group on Insect Venom Hypersensitivity., J Allergy Clin Immunol, 124, 1047, 10.1016/j.jaci.2009.08.027
Golden, 1997, Natural history of Hymenoptera venom sensitivity in adults., J Allergy Clin Immunol, 100, 760, 10.1016/S0091-6749(97)70270-7
Golden, 2013, Advances in diagnosis and management of insect sting allergy., Ann Allergy Asthma Immunol, 111, 84, 10.1016/j.anai.2013.05.026
Golden, 2001, Insect allergy with negative venom skin tests., J Allergy Clin Immunol, 107, 897, 10.1067/mai.2001.114706
Golden, 2009, Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom., Ann Allergy Asthma Immunol, 102, 47, 10.1016/S1081-1206(10)60107-X
Sturm, 2012, Ves v 5 can establish the diagnsosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe., J Allergy Clin Immunol, 130, 817, 10.1016/j.jaci.2012.05.047
Muller, 2009, Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5., Allergy, 64, 543, 10.1111/j.1398-9995.2008.01794.x
Hofmann, 2011, Added value of IgE detection to rApi m 1 and r Ves v 5 in patients with Hymenoptera venom allergy., J Allergy Clin Immunol, 127, 265, 10.1016/j.jaci.2010.06.042
Korosec, 2011, Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy., J Allergy Clin Immunol, 128, 671, 10.1016/j.jaci.2011.03.012
Sturm, 2011, Detection of IgE to recombinant Api m 1 and rVes v 5 is valuable but not sufficient to distinguish bee from wasp venom allergy., J Allergy Clin Immunol, 128, 247, 10.1016/j.jaci.2011.02.021
Korosec, 2012, High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy., J Allergy Clin Immunol, 129, 1406, 10.1016/j.jaci.2011.12.975
Mitterman, 2010, Recombinant allergen-based IgE testing to distinguish bee and wasp allergy., J Allergy Clin Immunol, 125, 1300, 10.1016/j.jaci.2010.03.017
Monsalve, 2012, Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization., Allergy, 67, 528, 10.1111/j.1398-9995.2011.02781.x
Muller, 2012, IgE to recombinant allergens Api m 1 Ves v 1, and Ves v 5 distinguish double sesnitization from crossreaction in venom allergy., Allergy, 67, 1069, 10.1111/j.1398-9995.2012.02847.x
Vos, 2013, Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venom., J Allergy Clin Immunol, 131, 1225, 10.1016/j.jaci.2012.07.041
Eberlein, 2012, Double positivity to bee and wasp venom: improved diagnostic procedure by recombinant allergen-based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants., J Allergy Clin Immunol, 130, 155, 10.1016/j.jaci.2012.02.008
Jakob, 2012, Comparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant-negative patients with bee venom allergy., J Allergy Clin Immunol, 130, 276, 10.1016/j.jaci.2012.03.048
Kohler, 2014, Component resolution reveals additional major allergens in patients with honeybee venon allergy., J Allergy Clin Immunol, 133, 1383, 10.1016/j.jaci.2013.10.060
Hamilton, 1993, Selection of Hymenoptera venoms for immunotherapy based on patients IgE antibody cross-reactivity., J Allergy Clin Immunol, 92, 651, 10.1016/0091-6749(93)90007-3
Blank, 2013, Polistes species venom is devoid of carbohydrate-based cross-reactivity and allows interference-free diagnostics., J Allergy Clin Immunol, 131, 1239, 10.1016/j.jaci.2012.10.047
MacGlashan, 1993, Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables., J Allergy Clin Immunol, 91, 605, 10.1016/0091-6749(93)90266-I
MacGlashan, 2013, Basophil activation testing., J Allergy Clin Immunol, 132, 777, 10.1016/j.jaci.2013.06.038
Kosnik, 2005, High sensitivity of basophils predicts side effects in venom immunotherapy., Allergy, 60, 1401, 10.1111/j.1398-9995.2005.00894.x
Zitnik, 2012, Monitoring honeybee venom immunotherapy in children with the basophil activation test., Pediatr Allergy Immunol, 23, 166, 10.1111/j.1399-3038.2011.01233.x
Korosec, 2009, Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results., Clin Exp Allergy, 39, 1730, 10.1111/j.1365-2222.2009.03347.x
Bonadonna, 2012, The role of basophil activation test in special populations with mastocytosis and reactions to Hymenoptera sting., Allergy, 67, 962, 10.1111/j.1398-9995.2012.02849.x
Korosec, 2012, Reply: Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe., J Allergy Clin Immunol, 130, 818, 10.1016/j.jaci.2012.05.048
Peternelj, 2008, Basophil sensitivity in patients not responding to venom immunotherapy., Int Arch Allergy Immunol, 146, 248, 10.1159/000116361
Kucera, 2010, Basophil activation can predict clinical sensitivity in patients after venom immunotherapy., J Investig Allergol Immunol, 20, 110
Haeberli, 2000, Sting challenge during venom immunotherapy for Hymenoptera venom allergy: the predictive value of basal serum tryptase level., Allergy, 55, 62
Ludolph-Hauser, 2001, Constitutively raised serum concentration of mast cell tryptase and severe anaphylactic reactions to Hymenoptera stings., Lancet, 357, 361, 10.1016/S0140-6736(00)03647-3
Haeberli, 2003, Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunoltherapy., Clin Exp Allergy, 33, 1216, 10.1046/j.1365-2222.2003.01755.x
Muller, 2009, Elevated baseline serum tryptase, mastocytosis and anaphylaxis., Clin Exp Allergy, 39, 620, 10.1111/j.1365-2222.2009.03251.x
Rueff, 2010, Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase., J Allergy Clin Immunol, 126, 105, 10.1016/j.jaci.2010.04.025
2009, M, deMonchy J, vanDoormaal JJ, et al. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy., Allergy, 64, 1237, 10.1111/j.1398-9995.2009.02118.x
Pravettoni, 2014, Basal platelet-activating factor acetylhydrolase: prognostic marker of severe Hymenoptera venom anaphylaxis., J Allergy Clin Immunol, 133, 1218, 10.1016/j.jaci.2013.10.033
Vadas, 2008, Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis., N Engl J Med, 358, 28, 10.1056/NEJMoa070030
Gilles, 2012, CD27 expression on allergen-specific T cells: a new surrogate for successful allergen-specific immunotherapy J Allergy Clin I, mmunol, 129, 552
Stoevesandt, 2012, Over- and underestimated parameters in severe Hymeneoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticariaangioedema., J Allergy Clin Immunol, 130, 698, 10.1016/j.jaci.2012.03.024